Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Limb Threatening Ischaemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT06416644
What this trial is testing

The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry)

Who this might be right for
Lower Limb IschemiaPeripheral Arterial DiseaseChronic Limb-Threatening Ischemia+9 more
Hospital do Divino Espírito Santo de Ponta Delgada 100
Not applicableStudy completedNCT03636867
What this trial is testing

Laboratory, Cellular and Molecular Determinants of Clinical Success in Diabetic Patients With Critical Limb Ischemia

Who this might be right for
Diabetes MellitusCritical Limb IschemiaCritical Lower Limb Ischemia+1 more
Maria Cecilia Hospital 236
Not applicableUnknownNCT03839953
What this trial is testing

Exercise Rehabilitation for Patients With Critical Limb Ischemia After Revascularization

Who this might be right for
Peripheral Arterial DiseaseCritical Limb Ischemia
University of Calgary 64
Post-approval studies (Phase 4)Study completedNCT00459888
What this trial is testing

Cryoplasty CLIMB-registry

Who this might be right for
Critical Limb IschemiaPeripheral Arterial Occlusive Disease
Flanders Medical Research Program 100
Not applicableStudy completedNCT07037979
What this trial is testing

Sarcopenia and Peripheral Artery Disease With Chronic Limb Threatening Ischemia

Who this might be right for
SarcopeniaPeripheral Arterial DiseaseChronic Limb Threatening Ischemia
Fudan University 97
Not applicableUnknownNCT05971394
What this trial is testing

IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

Who this might be right for
Infrapopliteal LesionsCritical Limb Ischemia
Biotyx Medical (Shenzhen) Co., Ltd. 100
Large-scale testing (Phase 3)Ended earlyNCT02144610
What this trial is testing

Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia

Who this might be right for
Critical Limb Ischemia
AnGes USA, Inc. 46
Not applicableStudy completedNCT02974179
What this trial is testing

A Long Term Follow-up Study of AMG0001 in Subjects With Critical Limb Ischemia

Who this might be right for
Critical Limb Ischemia
AnGes USA, Inc. 9
Testing effectiveness (Phase 2)UnknownNCT02145897
What this trial is testing

To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI

Who this might be right for
Critical Limb Ischemia
Kasiak Research Pvt. Ltd. 60
Not applicableUnknownNCT04737291
What this trial is testing

Drug Coated Ballon in Critical Limb Ischemia

Who this might be right for
Drug Coated Balloon
Assiut University 36
Large-scale testing (Phase 3)Ended earlyNCT03111238
What this trial is testing

The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

Who this might be right for
Peripheral Arterial Disease (PAD)Diabetes Mellitus (DM)Diabetes Mellitus, Type 1+3 more
Ixaka Ltd 3
Not applicableEnded earlyNCT03455374
What this trial is testing

Diamondback in Peripheral Vascular Disease

Who this might be right for
Peripheral Vascular DiseasesCritical Limb Ischemia
Arkansas Heart Hospital 10
Not applicableEnded earlyNCT01599442
What this trial is testing

Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia

Who this might be right for
Type 2 Diabetes MellitusDiabetic FootCritical Limb Ischemia
GWT-TUD GmbH 123
Early research (Phase 1)Study completedNCT03680105
What this trial is testing

A Safety and Tolerability Study of RJX Drug Product in Healthy Participants

Who this might be right for
Critical Limb Ischemia
Reven Pharmaceuticals, Inc. 76
Testing effectiveness (Phase 2)Study completedNCT02091921
What this trial is testing

Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study

Who this might be right for
Critical Limb Ischemia
University of Southern California 53
Not applicableNot Yet RecruitingNCT07340112
What this trial is testing

Expression of GLP1 Receptor on Peripheral Blood Mononuclear Cells in Advanced Peripheral Artery Disease: Paving the Way for GLP1R Agonists Treatment in Chronic Limb Threatening Ischemia

Who this might be right for
Peripheral Arterial Disease (PAD)Claudication, IntermittentChronic Limb-Threatening Ischemia
University Hospital, Strasbourg, France 50
Post-approval studies (Phase 4)Study completedNCT00906022
What this trial is testing

Self Expanding Nitinol Stent Versus Percutaneous Transluminal Arterial Angioplasty (PTA) With Optional Bailout Stenting in Case of PTA Failure in Patients With Symptomatic Critical Limb Ischemia or Severe Intermittent Claudication (EXPAND)

Who this might be right for
Patients With Symptomatic Critical Limb IschemiaSevere Intermittent Claudication
Biotronik AG 94
Early research (Phase 1)UnknownNCT06359912
What this trial is testing

Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia

Who this might be right for
Critical Limb Ischemia
Allife Medical Science and Technology Co., Ltd. 27
Not applicableActive Not RecruitingNCT06656364
What this trial is testing

Esprit BTK Post-Approval Study

Who this might be right for
Chronic Limb-Threatening Ischemia
Abbott Medical Devices 200
Testing effectiveness (Phase 2)Ended earlyNCT03968198
What this trial is testing

Administration of Adipose-derived Stem Cells (ASC) in Patient With Critical Limb Ischemia.

Who this might be right for
Critical Limb Ischemia and Peripheral Artery Disease
University Hospital, Toulouse 2
Next Page